Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.
Journal: American journal of hematology
Year: June 10, 2024
Hematologist-Oncologist
5
No OPD information available
Follicular Lymphoma
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Non-Hodgkin Lymphoma
B-Cell Lymphoma
Classical Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Hodgkin Lymphoma
Mononucleosis
Muhammed B. Sabdia is a male healthcare provider who helps patients with various types of lymphomas, including Follicular Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, and Mononucleosis.
Muhammed B. Sabdia uses special skills and treatments to care for patients with these conditions. He is known for his ability to diagnose and treat different types of lymphomas effectively.
Patients trust Muhammed B. Sabdia because he communicates with them in a friendly and clear way. He listens to their concerns and explains medical information in a simple and understandable manner.
To stay updated with the latest medical knowledge and research, Muhammed B. Sabdia regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals. This helps him provide the best care for his patients based on the most current information available.
Muhammed B. Sabdia works well with colleagues and values teamwork in healthcare. He respects the expertise of other medical professionals and believes that working together leads to better outcomes for patients.
Muhammed B. Sabdia's work has positively impacted many patients' lives by providing accurate diagnoses, effective treatments, and compassionate care. Patients have reported feeling better physically and emotionally under his care.
One of Muhammed B. Sabdia's notable publications is "Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma," published in the American Journal of Hematology on June 10, 2024. This research contributes to the understanding of immune biomarkers in lymphomas, helping to improve treatment strategies for patients.
Muhammed B. Sabdia's dedication to patient care, commitment to staying informed, and contributions to medical research make him a respected healthcare provider in the field of lymphomas.
Journal: American journal of hematology
Year: June 10, 2024
Dr. Sabdia is a caring and knowledgeable Hematologist-Oncologist. He explained everything clearly and made me feel at ease throughout my treatment.
I highly recommend Dr. Sabdia for anyone seeking a compassionate and skilled Hematologist-Oncologist in Brisbane. He truly goes above and beyond for his patients.
Dr. Sabdia is an exceptional Hematologist-Oncologist. His expertise and genuine concern for his patients make all the difference in their journey to recovery.
I am grateful for Dr. Sabdia's dedication to his patients as a Hematologist-Oncologist. He is not only a great doctor but also a supportive and understanding individual.
Dr. Sabdia is a Hematologist-Oncologist who truly cares about his patients' well-being. His compassionate approach and expertise make him stand out in his field.
I had a positive experience with Dr. Sabdia as my Hematologist-Oncologist. He provided excellent care and support, making me feel confident in my treatment plan.
Dr. Sabdia is a top-notch Hematologist-Oncologist in Brisbane. His professionalism and kindness make a significant impact on his patients' healing journey.
I am thankful for Dr. Sabdia's expertise as a Hematologist-Oncologist. He is not only knowledgeable but also empathetic towards his patients' needs.
Dr. Sabdia is a Hematologist-Oncologist who truly cares about his patients' well-being. His dedication and expertise shine through in his approach to treatment.